Lithium-discontinuation-induced Treatment Refractoriness Revisited

Overview

Journal Int J Bipolar Disord

Date 2024 May 15

PMID 38750382

Authors

Ralph Kupka

Eline Regeer

Annet van Bergen

Leonardo Tondo

Michael Bauer

Affiliations

Soon will be listed here.

Abstract

Background: Lithium is effective in the long-term treatment of bipolar disorder. Concerns have been raised about non-responsiveness after discontinuation and resuming previously effective lithium prophylaxis. We reviewed the available literature on this so-called lithium-discontinuation-induced treatment refractoriness (LDITR).

Results: We found 11 case reports and six cohort studies including 403 patients addressing LDITR, and one nation-wide register study providing some additional data on LDITR. Pooling all cohort studies, the percentages of non-responders during re-treatment with lithium ranged from 3.6 to 27.7%, with an average of 17.3%. Non-responsiveness was associated with longer duration of lithium treatment before discontinuation, longer duration of bipolar disorder before start of lithium, faster tapering off lithium, and longer duration of discontinuation.

Conclusions: There may be a subgroup in whom lithium discontinuation-induced treatment refractoriness exists. However, the vast majority of people respond when lithium is restarted. Moreover, it may be necessary to continue lithium beyond the first relapses to restore long-term prophylactic efficacy.

References

Koukopoulos A, Reginaldi D, Minnai G, Serra G, Pani L, Johnson F . The long term prophylaxis of affective disorders. Adv Biochem Psychopharmacol. 1995; 49:127-47. View

Franks M, Macritchie K, Mahmood T, Young A . Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study. J Psychopharmacol. 2008; 22(4):452-6. DOI: 10.1177/0269881107085238. View

Coryell W, Solomon D, Leon A, Akiskal H, Keller M, Scheftner W . Lithium discontinuation and subsequent effectiveness. Am J Psychiatry. 1998; 155(7):895-8. DOI: 10.1176/ajp.155.7.895. View

Fornaro M, Stubbs B, De Berardis D, Iasevoli F, Solmi M, Veronese N . Does the "" Lose its Shine Over the Time? Assessment of Loss of Lithium Response in a Preliminary Sample of Bipolar Disorder Outpatients. Clin Pract Epidemiol Ment Health. 2017; 12:142-157. PMC: 5278557. DOI: 10.2174/1745017901612010142. View

Appleby B, Wise T, Isaac A . A case of refractoriness to lithium therapy following its discontinuation in a previously responsive patient. Harv Rev Psychiatry. 2006; 14(6):330-2. DOI: 10.1080/10673220601070039. View

Maj M, Pirozzi R, Magliano L . Nonresponse to reinstituted lithium prophylaxis in previously responsive bipolar patients: prevalence and predictors. Am J Psychiatry. 1995; 152(12):1810-1. DOI: 10.1176/ajp.152.12.1810. View

Puglisi-Allegra S, Ruggieri S, Fornai F . Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders. Transl Psychiatry. 2021; 11(1):366. PMC: 8257731. DOI: 10.1038/s41398-021-01492-7. View

Joyce K, Thompson A, Marwaha S . Is treatment for bipolar disorder more effective earlier in illness course? A comprehensive literature review. Int J Bipolar Disord. 2016; 4(1):19. PMC: 5017982. DOI: 10.1186/s40345-016-0060-6. View

de Vries C, van Bergen A, Regeer E, Benthem E, Kupka R, Boks M . The effectiveness of restarted lithium treatment after discontinuation: reviewing the evidence for discontinuation-induced refractoriness. Bipolar Disord. 2013; 15(6):645-9. DOI: 10.1111/bdi.12105. View

10.

Collumbien E . [Risk of inducing resistance upon stopping and restarting lithium after long-term usage]. Ned Tijdschr Geneeskd. 2000; 144(21):1022-3. View

11.

Baldessarini R, Tondo L, Ghiani C, Lepri B . Illness risk following rapid versus gradual discontinuation of antidepressants. Am J Psychiatry. 2010; 167(8):934-41. DOI: 10.1176/appi.ajp.2010.09060880. View

12.

Cakir S, Yazici O, Post R . Decreased responsiveness following lithium discontinuation in bipolar disorder: A naturalistic observation study. Psychiatry Res. 2016; 247:305-309. DOI: 10.1016/j.psychres.2016.11.046. View

13.

Papiol S, Schulze T, Heilbronner U . Lithium response in bipolar disorder: Genetics, genomics, and beyond. Neurosci Lett. 2022; 785:136786. DOI: 10.1016/j.neulet.2022.136786. View

14.

Dervic K, Sher L, Galfalvy H, Grunebaum M, Burke A, Sullivan G . Antisuicidal effect of lithum in bipolar disorder: is there an age-specific effect?. J Affect Disord. 2023; 341:8-11. DOI: 10.1016/j.jad.2023.08.107. View

15.

Holm M, Tanskanen A, Lahteenvuo M, Tiihonen J, Taipale H . Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder. Eur Neuropsychopharmacol. 2022; 61:36-42. DOI: 10.1016/j.euroneuro.2022.05.012. View

16.

Baldessarini R, Tondo L, Viguera A . Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord. 2001; 1(1):17-24. DOI: 10.1034/j.1399-5618.1999.10106.x. View

17.

Rybakowski J . Response to lithium in bipolar disorder: clinical and genetic findings. ACS Chem Neurosci. 2014; 5(6):413-21. PMC: 4063501. DOI: 10.1021/cn5000277. View

18.

Bauer M . Refractoriness induced by lithium discontinuation despite adequate serum lithium levels. Am J Psychiatry. 1994; 151(10):1522. DOI: 10.1176/ajp.151.10.1522. View

19.

Goes F . Diagnosis and management of bipolar disorders. BMJ. 2023; 381:e073591. DOI: 10.1136/bmj-2022-073591. View

20.

Tondo L, Baldessarini R, Floris G, Rudas N . Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders. Am J Psychiatry. 1997; 154(4):548-50. DOI: 10.1176/ajp.154.4.548. View